Demonstrates the efficacy of sulbactam-durlobactam and cefiderocol in abscess treatment, highlighting potential in cystic fibrosis patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gaglani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: